Can oral Bactrim (trimethoprim/sulfamethoxazole) and clindamycin be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Taking Oral Bactrim and Clindamycin Together

Yes, oral Bactrim (trimethoprim/sulfamethoxazole) and clindamycin can be taken together when clinically indicated, as there are no significant drug interactions between these two antibiotics that would contraindicate their concurrent use.

Rationale for Combination Use

The combination of these antibiotics may be appropriate in certain clinical scenarios:

  1. Expanded Coverage:

    • Bactrim provides good coverage against many gram-negative organisms and some gram-positive bacteria
    • Clindamycin offers excellent coverage against gram-positive organisms (including some MRSA) and anaerobes
  2. Specific Clinical Indications:

    • Animal bites: For patients with severe penicillin allergies, the combination of trimethoprim-sulfamethoxazole plus clindamycin is recommended 1
    • Polymicrobial infections: When both gram-positive and gram-negative coverage is needed
    • Certain skin and soft tissue infections: Particularly those involving suspected MRSA 2

Evidence Supporting Combination Use

  • In vitro studies have shown that clindamycin in combination with other antibiotics typically shows no antagonistic effects against common infectious microorganisms and may even demonstrate synergistic effects 3

  • Clinical studies comparing Bactrim and clindamycin individually for MRSA skin infections have shown similar efficacy rates, suggesting they can be effective when used appropriately 4, 2

Considerations When Using This Combination

Potential Side Effects to Monitor

  1. Gastrointestinal effects:

    • Both medications can cause diarrhea
    • Increased risk of Clostridioides difficile infection
    • Monitor for severe diarrhea or abdominal pain
  2. Skin reactions:

    • Both medications can cause rash
    • Bactrim has higher risk of severe skin reactions (Stevens-Johnson syndrome)
  3. Hematologic effects:

    • Bactrim can cause bone marrow suppression
    • Monitor for unusual bleeding or bruising
  4. Electrolyte abnormalities:

    • Bactrim can cause hyperkalemia and hyponatremia, especially at high doses 5

Dosing Considerations

  • Standard adult dosing:

    • Bactrim DS: 1-2 tablets (160mg TMP/800mg SMX per tablet) every 12 hours
    • Clindamycin: 300-450mg every 6-8 hours
  • Renal adjustment:

    • Bactrim requires dose adjustment when creatinine clearance is <30 mL/min 6
    • Clindamycin does not typically require renal adjustment

Special Populations

Pediatric Patients

  • For children with MRSA infections, if using clindamycin: 10-13 mg/kg/dose IV every 6-8 hours (to administer 40 mg/kg/day) 1
  • Pediatric Bactrim dosing is weight-based

Pregnancy

  • Both medications are generally avoided in pregnancy when possible, but the benefits may outweigh risks in serious infections

Clinical Pearls

  1. Always consider source control: For abscesses, incision and drainage remains critical regardless of antibiotic choice 2

  2. Duration of therapy should be determined by the specific infection being treated:

    • Uncomplicated skin infections: 5-10 days
    • Complicated skin/soft tissue infections: 7-14 days
    • Osteomyelitis: 4-6 weeks 7
  3. Monitor for adverse effects more closely when using combination therapy, as the risk of side effects may be additive

  4. Ensure adequate hydration to prevent crystalluria with Bactrim 5

By following these guidelines and monitoring appropriately, the combination of oral Bactrim and clindamycin can be used effectively and safely when clinically indicated.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.

Journal of the American Board of Family Medicine : JABFM, 2010

Research

Trimethoprim-sulfamethoxazole.

Mayo Clinic proceedings, 1991

Guideline

Management of Implant-Related Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.